1.17% 0.0071

Orgenesis Inc (ORGS)

Relative Volume:

Orgenesis Inc Stock (ORGS) Company Profile

Orgenesis Inc

(480) 659-6404

20271 GOLDENROD LANE, GERMANTOWN, MD

최신 SEC 제출 서류

ORGS's Discussions on Twitter

Orgenesis Inc Stock (ORGS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2018-12-20	개시	Dawson James	Buy

Orgenesis Inc 주식(ORGS)의 최신 뉴스

Orgenesis Inc (ORGS) 재무 분석

Orgenesis Inc 주식 (ORGS) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Safier Jacob	10% Owner	Feb 01 '24	Buy	0.33	10,100	3,332	3,110,100
Safier Jacob	10% Owner	Sep 21 '23	Buy	0.69	100,000	68,950	2,839,860
Safier Jacob	10% Owner	Nov 02 '23	Buy	0.84	20,000	16,888	2,920,000
Safier Jacob	10% Owner	Sep 28 '23	Buy	0.67	25,000	16,780	2,864,860
Safier Jacob	10% Owner	Nov 08 '23	Buy	0.71	20,000	14,188	2,940,000
Safier Jacob	10% Owner	Nov 09 '23	Buy	0.65	20,000	13,054	2,960,000
Safier Jacob	10% Owner	Oct 24 '23	Buy	0.90	10,000	8,999	2,890,563
Safier Jacob	10% Owner	Jan 30 '24	Buy	0.33	25,000	8,245	3,095,000
Safier Jacob	10% Owner	Oct 05 '23	Buy	0.80	10,000	8,030	2,874,860
Safier Jacob	10% Owner	Jan 26 '24	Buy	0.32	25,000	8,000	3,070,000

Orgenesis Inc (ORGS)

Orgenesis Inc Stock (ORGS) Company Profile

Orgenesis Inc Stock (ORGS) Upgrades & Downgrades

Orgenesis Inc 주식(ORGS)의 최신 뉴스

Artificial Insemination Market May See Big Move: Vitrolife, Orgenesis, CryoLife - openPR

Cell therapy weekly: US FDA grants Orphan Drug Designation to a gene therapy for a type of retinal disease - RegMedNet

Orgenesis Inc (ORGS) is looking forward to a strong quarter - SETE News

Upward Trajectory: Orgenesis Inc (ORGS) Posts a Slidee, Closing at 0.67 - The Dwinnex

Orgenesis’ CAR-T ORG-101 Demonstrates Efficacy and Safety in Acute Lymphoblastic Leukemia in Real-World Study in China - CGTLive™

Orgenesis reports promising CAR-T therapy results - Investing.com India

Orgenesis Releases Investor Presentation and Regulatory Update - TipRanks

Orgenesis reports promising CAR-T therapy results - Investing.com

Orgenesis reports promising CAR-T therapy results By Investing.com - Investing.com UK

Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - StockTitan

Orgenesis Inc. secures additional $750K funding - Investing.com India

Orgenesis Inc. secures additional $750K funding By Investing.com - Investing.com Canada

Orgenesis Inc. secures additional $750K funding By Investing.com - Investing.com UK

Pfizer Does Not Own Orgenesis: So Why Does This Misinformation Trend on X? - PANDA

Orgenesis Inc (ORGS) can make a big difference with a little luck - SETE News

Orgenesis stock hits 52-week high at $1.04 amid market fluctuations - Investing.com

Orgenesis forms joint venture with Harley Street Healthcare Group - Investing.com

Orgenesis forms joint venture with Harley Street Healthcare Group - Investing.com India

Orgenesis forms joint venture with Harley Street Healthcare - Investing.com

Orgenesis forms joint venture with Harley Street Healthcare - Investing.com India

Orgenesis Inc Inc. (ORGS) Price Performance: The Impact of Insider Trading and Institutional Holdings - The InvestChronicle

Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - StockTitan

Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Orgenesis Provides Second Quarter 2024 Business Update - ForexTV.com

Orgenesis Provides Second Quarter 2024 Business Update - StockTitan

BioIVT Opens Facility With New Cleanroom From Germfree In Winchester VA - Pharmaceutical Online

Who are the leading innovators in GLP-1 analogues for the pharmaceutical industry? - Pharmaceutical Technology

Orgenesis Inc [ORGS] Investment Guide: What You Need to Know - Knox Daily

Investor’s Delight: Orgenesis Inc (ORGS) Closes Strong at 0.64, Up 14.64 - The Dwinnex

Orgenesis (NASDAQ:ORGS) Shares Up 14.6% - Defense World

ORGS: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Check Out Kintara Therapeutics Inc (KTRA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Anixa Biosciences Secures FDA Clearance to Redose Single Patient in Ovarian Cancer CER-T Trial - CGTLive™

No, Ursula von der Leyen's husband does not work for a company owned by Pfizer - logicallyfacts.com

Common Warts Treatment Market Statistical Forecast, Trade Analysis 2024 – 2031 - WhaTech

Oncolytic Virus Cancer Therapy Pipeline Report 2024: Companies, Therapies, Latest FDA, EMA, Approvals by - EIN News

Orgenesis Announces Board Reshuffle and New Audit Member - TipRanks

Regenerative Xenograft Market Revenue and Size Outlook | Organovo Holdings Inc, Athersys Inc, RenovaCare Inc ... - Economica

Onconase (Ranpirnase) | Benefits and Side Effects - Mesothelioma.net Blog

FlexShopper director Howard Dvorkin buys $20,023 in company stock By Investing.com - Investing.com India

Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com Australia

Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com Canada

Orgenesis Inc. expands equity incentive plan by 9 million shares By Investing.com - Investing.com

Orgenesis Annual Meeting: Board Changes and Share Increase - TipRanks

Investing in Orgenesis Inc (ORGS): What You Must Know – Knox Daily - Knox Daily

ORGS’s Stock Journey: What Investors Need to Know About Orgenesis Inc’s Performance - The InvestChronicle

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day ... - Benzinga

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga

Short Interest in Orgenesis Inc. (NASDAQ:ORGS) Decreases By 17.6% - Defense World

Form 424B3 Orgenesis Inc. - StreetInsider.com

Orgenesis (NASDAQ:ORGS) Stock Price Down 2.4% - Defense World

Orgenesis Inc (ORGS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Orgenesis Inc 주식 (ORGS) 내부자 거래

ORGS과 유사한 종목